Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey
暂无分享,去创建一个
Luigi Tavazzi | Ulf Dahlström | L. Tavazzi | A. Maggioni | A. Voors | R. Urso | U. Dahlström | K. Damman | Aldo P Maggioni | Adriaan A Voors | Vincent M van Deursen | Kevin Damman | Renato Urso | Cecile Laroche | C. Laroche | V. M. van Deursen
[1] H. Hillege,et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. , 2010, Journal of cardiac failure.
[2] K. Swedberg,et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. , 2005, European heart journal.
[3] G. Fonarow,et al. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. , 2005, American heart journal.
[4] A. Voors,et al. Erythropoietin in cardiovascular diseases. , 2004, European heart journal.
[5] Colin Simpson,et al. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland , 2010, European journal of heart failure.
[6] M. Arzt,et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study , 2011, European journal of heart failure.
[7] S. Javaheri,et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. , 1998, Circulation.
[8] D. J. Veldhuisen,et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality , 2010, European journal of heart failure.
[9] A. Voors,et al. Diabetes: a driver for heart failure , 2011, Heart.
[10] J. Vestbo,et al. The prognostic importance of lung function in patients admitted with heart failure , 2010, European journal of heart failure.
[11] M. Levin,et al. The occurrence of lung cancer in man. , 1953, Acta - Unio Internationalis Contra Cancrum.
[12] A. Simonds,et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction , 2007, European journal of heart failure.
[13] X. Drouot,et al. Prognostic impact of sleep‐disordered breathing and its treatment with nocturnal ventilation for chronic heart failure , 2012, European journal of heart failure.
[14] Helmut Baumgartner,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, European journal of heart failure.
[15] D. Reda,et al. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. , 2007, American Journal of Medicine.
[16] T. Horwich,et al. Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. , 2012, The American journal of cardiology.
[17] Daniel R. Miller,et al. Final report , 2000 .
[18] H. Tsutsui. [Candesartan in heart failure: assessment of reduction in mortality and morbidity]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.
[19] M. Weatherall,et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. , 2005, Chest.
[20] P. Poole‐Wilson,et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey , 2005 .
[21] S. Allender,et al. European cardiovascular disease statistics , 2008 .
[22] P. Saxena,et al. Organ blood flow protection in hypertension and congestive heart failure. , 1993, The American journal of medicine.
[23] Levin Ml,et al. The occurrence of lung cancer in man. , 1953, Acta - Unio Internationalis Contra Cancrum.
[24] Frank Edelmann,et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction , 2011, Clinical Research in Cardiology.
[25] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[26] G. Navis,et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.
[27] V. Somers,et al. Central Sleep Apnea in Left Ventricular Dysfunction: Prevalence and Implications for Arrhythmic Risk , 2003, Circulation.
[28] H. Akre,et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. , 2011, Journal of cardiac failure.
[29] R. Zelis,et al. Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. , 1988, The American journal of cardiology.
[30] Sameer Ather,et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. , 2012, Journal of the American College of Cardiology.
[31] J. McMurray,et al. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure , 2007, Heart.
[32] S. Javaheri,et al. Occult Sleep-Disordered Breathing in Stable Congestive Heart Failure , 1995, Annals of Internal Medicine.
[33] H. Strömer,et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the Mahler survey. , 2006, European heart journal.
[34] S. Javaheri. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. , 2006, International journal of cardiology.
[35] A. Remppis,et al. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy , 2008, Clinical Research in Cardiology.
[36] J. McMurray,et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology , 2009, European journal of heart failure.
[37] Ramon Luengo-Fernandez,et al. European Cardiovascular Disease Statistics 2017 , 2012 .
[38] J. Cohn,et al. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. , 1984, Circulation.
[39] Dieter Horstkotte,et al. Sleep‐disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients , 2007, European journal of heart failure.
[40] H. Hillege,et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. , 2008, Journal of the American College of Cardiology.
[41] M. Ezzati,et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.
[42] Jessica Ogarek,et al. Patterns of Comorbidity in Older Adults with Heart Failure: The Cardiovascular Research Network PRESERVE Study , 2013, Journal of the American Geriatrics Society.
[43] D. J. Veldhuisen,et al. Co-morbidities in heart failure , 2014, Heart Failure Reviews.
[44] Albert W Wu,et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.
[45] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[46] P. Ponikowski,et al. EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.
[47] N. Bayley,et al. Failure , 1890, The Hospital.
[48] G. Tognoni,et al. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure , 2007, European journal of heart failure.